Medicina
Departamento
Hospital Juan Ramón Jiménez
Huelva, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Juan Ramón Jiménez (21)
2023
-
miR-21-5p promotes NASH-related hepatocarcinogenesis
Liver International, Vol. 43, Núm. 10, pp. 2256-2274
2022
-
A bacteraemia risk prediction model: development and validation in an emergency medicine population
Infection, Vol. 50, Núm. 1, pp. 203-221
-
Cryoballoon Ablation for Persistent and Paroxysmal Atrial Fibrillation: Procedural Differences and Results from the Spanish Registry (RECABA)
Journal of Clinical Medicine, Vol. 11, Núm. 5
-
Effectiveness and safety of dapagliflozin in real-life patients: data from the DAPA-RWE Spanish multicentre study
Drugs in Context, Vol. 11
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2021
-
Use of antihyperglycaemic therapy with cardiovascular benefit in patients with type 2 diabetes who require hospitalisation: A cross-sectional study
Revista Clinica Espanola, Vol. 221, Núm. 9, pp. 517-528
2020
-
Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)
Scientific Reports, Vol. 10, Núm. 1
2019
-
DALBACEN cohort: Dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
Annals of Clinical Microbiology and Antimicrobials, Vol. 18, Núm. 1
-
Effectiveness and safety of the switch from remicade® to CT-P13 in patients with inflammatory bowel disease
Journal of Crohn's and Colitis, Vol. 13, Núm. 11, pp. 1380-1386
-
Role of age and comorbidities in mortality of patients with infective endocarditis
European Journal of Internal Medicine, Vol. 64, pp. 63-71
2017
-
Evolution after Anti-TNF Discontinuation in Patients with Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study
American Journal of Gastroenterology, Vol. 112, Núm. 1, pp. 120-131
-
Prognostic accuracy of SIRS criteria, qSOFA score and GYM score for 30-day-mortality in older non-severely dependent infected patients attended in the emergency department
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 12, pp. 2361-2369
-
Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253
2015
-
Current epidemiology and outcome of infective endocarditis: A multicenter, prospective, cohort study
Medicine (United States), Vol. 94, Núm. 43
-
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784
-
Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis
World Journal of Gastroenterology, Vol. 21, Núm. 30, pp. 9163-9174
2013
-
Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis
Clinical Infectious Diseases, Vol. 56, Núm. 9, pp. 1261-1268
-
Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of staphylococcus aureus bacteremia
Clinical Infectious Diseases, Vol. 57, Núm. 9, pp. 1225-1233
2011
-
Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C
Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 6, pp. 1346-1350
2009
-
Progress in cardiac pacing
Revista Espanola de Cardiologia, Vol. 62, Núm. SUPPL. 1, pp. 117-128